Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Emmaus Life Sciences, Inc. | s102639_10q.htm |
| EX-31.1 - EXHIBIT 31-1 - Emmaus Life Sciences, Inc. | s102639_ex31-1.htm |
| EX-31.2 - EXHIBIT 31-2 - Emmaus Life Sciences, Inc. | s102639_ex31-2.htm |
| EX-10.27 - EXHIBIT 10.27 - Emmaus Life Sciences, Inc. | s102639_ex10-27.htm |
| EX-10.30 - EXHIBIT 10.30 - Emmaus Life Sciences, Inc. | s102639_ex10-30.htm |
| EX-10.31 - EXHIBIT 10.31 - Emmaus Life Sciences, Inc. | s102639_ex10-31.htm |
| EX-10.28 - EXHIBIT 10.28 - Emmaus Life Sciences, Inc. | s102639_ex10-28.htm |
| EX-10.29 - EXHIBIT 10.29 - Emmaus Life Sciences, Inc. | s102639_ex10-29.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended December 31, 2015 (the “Report”) by MYnd Analytics, Inc.. (the “Registrant”), the undersigned hereby certifies that to the best of his knowledge:
1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| Date: February 16, 2016 | /s/ George Carpenter |
| George Carpenter | |
| Chief Executive Officer (Principal Executive Officer) | |
| Date: February 16, 2016 | /s/ Paul Buck |
| Paul Buck | |
| Chief Financial Officer (Principal Financial Officer) |